Tillo, Carmilo A.
HRN: 06-58-95 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/06/2024
10/13/2024
IV
500mg
Q8
T/C Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes